Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells

被引:22
作者
Bosier, Barbara [2 ]
Lambert, Didier M. [2 ]
Hermans, Emmanuel [1 ]
机构
[1] Catholic Univ Louvain, Lab Pharmacol Expt UCL 5410, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Unite Chim Pharmaceut & Radiopharm UCL 7340, B-1200 Brussels, Belgium
来源
FEBS LETTERS | 2008年 / 582卷 / 28期
关键词
Functional selectivity; Cannabinoid receptor; Tyrosine hydroxylase; MAPK; Drug efficacy; G Protein coupled receptor;
D O I
10.1016/j.febslet.2008.10.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Agonists acting at the CB1 cannabinoid receptor in N1E-115 neuroblastoma cells were found to activate MAPK family members with reciprocal efficacies. Thus, HU 210 robustly increased phosphorylation of ERK1/2 whereas CP 55,940 was more effective in activating JNK. The use of selected kinase inhibitors confirmed that distinct signalling cascades were involved in these responses. This reciprocal control of MAPK activity was correlated with the observation that HU 210- and CP 55,940-mediated regulations of tyrosine hydroxylase gene expression were respectively impaired by MEK and JNK inhibitors. These data indicate that complex interactions of the CB1 receptor with intracellular signalling partners controlling MAPK activities may explain the apparent disparities in cellular responses to functional selective agonists. (C) 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3861 / 3867
页数:7
相关论文
共 44 条
[1]   Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[2]   The stimulatory effect of cannabinoids on calcium uptake is mediated by Gs GTP-binding proteins and CAMP formation [J].
Bash, R ;
Rukovitch, V ;
Gafni, M ;
Sarne, Y .
NEUROSIGNALS, 2003, 12 (01) :39-44
[3]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[4]  
Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884
[5]   Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor [J].
Bosier, B. ;
Hermans, E. ;
Lambert, D. M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (01) :24-33
[6]   Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line [J].
Bosier, Barbara ;
Tilleux, Sebastien ;
Najimi, Mustapha ;
Lambert, Didier M. ;
Hermans, Emmanuel .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (06) :1996-2007
[7]   Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance [J].
Bosier, Barbara ;
Hermans, Emmanuel .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (08) :438-446
[8]   ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY STIMULATION OF THE CENTRAL CANNABINOID RECEPTOR CB1 [J].
BOUABOULA, M ;
POINOTCHAZEL, C ;
BOURRIE, B ;
CANAT, X ;
CALANDRA, B ;
RINALDICARMONA, M ;
LEFUR, G ;
CASELLAS, P .
BIOCHEMICAL JOURNAL, 1995, 312 :637-641
[9]  
Breivogel CS, 2000, J PHARMACOL EXP THER, V295, P328
[10]   Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain [J].
Burkey, TH ;
Quock, RM ;
Consroe, P ;
Ehlert, FJ ;
Hosohata, Y ;
Roeske, WR ;
Yamamura, HI .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 336 (2-3) :295-298